Pietropaoli Anthony P, Glance Laurent G, Oakes David, Fisher Susan G
Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA.
Gend Med. 2010 Oct;7(5):422-37. doi: 10.1016/j.genm.2010.09.005.
Although the incidence of sepsis is higher in men than in women, it is controversial whether there are sex-based differences in sepsis-associated mortality.
The aim of this study was to test the hypothesis that hospital mortality is higher in males compared with females with severe sepsis/septic shock who require intensive care.
This was a retrospective cohort study of intensive care unit (ICU) patients hospitalized (in 98 ICUs in 71 US hospitals and 4 Canadian or Brazilian hospitals) with severe sepsis/septic shock between mid-2003 and 2006, using data from the Cerner Project IMPACT database.
Data were analyzed for 18,757 ICU patients (median age, 66 years; interquartile range, 53-77 years), including 8702 females (46%). Hospital mortality was higher in female patients compared with male patients (35% vs 33%, respectively; P = 0.006). After adjusting for differences in baseline characteristics and processes of care, females had a higher likelihood of hospital mortality than did males (odds ratio [OR] = 1.11; 95% CI, 1.04-1.19; P = 0.002). Female patients were less likely than male patients to receive deep venous thrombosis prophylaxis (OR = 0.90; 95% CI, 0.84-0.97), invasive mechanical ventilation (OR = 0.81; 95% CI, 0.76-0.86), or hemodialysis catheters (OR = 0.85; 95% CI, 0.78-0.93). Females were more likely than males to receive red blood cell transfusions (OR = 1.15; 95% CI, 1.09-1.22) and code status limitations (OR = 1.31; 95% CI, 1.18-1.47).
In this large cohort of ICU patients, females with severe sepsis/septic shock had a higher risk of dying in the hospital than did males. This difference remained after multivariable adjustment. Significant gender disparities were also found in some aspects of care delivery, but these did not explain the higher mortality in female patients.
尽管脓毒症在男性中的发病率高于女性,但脓毒症相关死亡率是否存在性别差异仍存在争议。
本研究旨在验证以下假设:与需要重症监护的严重脓毒症/脓毒性休克女性患者相比,男性患者的医院死亡率更高。
这是一项回顾性队列研究,研究对象为2003年年中至2006年期间在美国71家医院的98个重症监护病房(ICU)以及4家加拿大或巴西医院住院治疗的严重脓毒症/脓毒性休克ICU患者,使用的是Cerner项目IMPACT数据库中的数据。
对18757例ICU患者(中位年龄66岁;四分位间距53 - 77岁)进行了数据分析,其中包括8702名女性(46%)。女性患者的医院死亡率高于男性患者(分别为35%和33%;P = 0.006)。在对基线特征和护理过程中的差异进行调整后,女性患者的医院死亡可能性高于男性(优势比[OR]=1.11;95%置信区间,1.04 - 1.19;P = 0.002)。女性患者接受深静脉血栓形成预防措施、有创机械通气或血液透析导管的可能性低于男性患者(OR分别为0.90;95%置信区间,0.84 - 0.97;OR为0.81;95%置信区间,0.76 - 0.86;OR为0.85;95%置信区间,0.78 - 0.93)。女性患者接受红细胞输血和代码状态限制的可能性高于男性(OR分别为1.15;95%置信区间,1.09 - 1.22;OR为1.31;95%置信区间,1.18 - 1.47)。
在这一大型ICU患者队列中,患有严重脓毒症/脓毒性休克的女性患者在医院死亡的风险高于男性。多变量调整后,这种差异仍然存在。在护理提供的某些方面也发现了显著的性别差异,但这些并不能解释女性患者较高的死亡率。